MEDRELEAF CORP T.LEAF

Healthcare Drug Manufacturers - Specialty & Generic

"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."

TSX:LEAF - Post by User

MEDRELEAF CORP > Why LEAF only 3.7% up today.

<< Previous

Bullboard Posts

Next >>

Comment by Mining_Dudeon May 14, 2018 1:52pm

294 Views

Post# 28027756

RE:RE:Why LEAF only 3.7% up today.

APH trades at a low multiple because of its precieved lower quality bud

MartialArts wrote:
Review what just happened to Cannimed holders. They were promised $12.86 per share and the stock trades less than $8 a share today.

ACB value has been called "monopoly money" by the Cannimed CEO. He negociated a cash component and ran.

With ACB+LEAF, it's an "all share" so you aren't getting $28, you're getting $28 worth of ACB monopoly money. Far safer to invest in WEED or APH.

APH is severely undervalued and not a clear take-over candidate by Canopy. If Canopy wants to stay #1, it seriously has to start talkin to APH.